Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Women with PCOS experience more psychological symptoms and need emotional support.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Powered exoskeleton training improves body perception and quality of life in spinal cord injury patients.

Ultrasound and Doppler analysis are valuable tools for diagnosing and understanding polycystic ovary syndrome.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Comprehensive information and trained nurses are crucial for a better scalp cooling experience during chemotherapy.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Lower family income is linked to more stress in parents and more behavior problems in children.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

Hair loss in men is common, treatable, but not curable.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Finasteride effectively treats male hair loss, increasing length and thickness.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

PRP injections improve hair density and thickness in women with hair loss.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

QR678 treatments were more effective and comfortable for male hair loss than PRP treatments.

Obesity and negative body image harm mental health and quality of life in women with PCOS.